Communication & Screening Intervention for Lung Cancer
Trial Summary
What is the purpose of this trial?
To test the impact of a multilevel intervention on primary (provider-patient communication, intentions, and knowledge) and secondary (screening referrals and completion) outcomes.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Provider Prompt & Patient Outreach and Education for lung cancer?
How does this lung cancer screening intervention differ from other treatments?
This lung cancer screening intervention is unique because it focuses on improving communication and education about screening, using both print and web-based materials to engage participants and increase awareness. It also adapts to different delivery modes, such as in-person and phone sessions, to effectively reach diverse populations and improve screening adherence.26789
Eligibility Criteria
This trial is for English-speaking individuals aged 50-80 who currently smoke or quit within the last 15 years, have a history of heavy smoking (20+ pack-years), and haven't had lung screening in over 13 months. They must be scheduled for an upcoming clinic appointment and able to consent and complete interviews. Those with a history of lung cancer cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants and providers engage in a multilevel intervention to address health disparities in lung cancer screening
Follow-up
Participants are monitored for lung cancer screening knowledge, intentions, and completion rates
Treatment Details
Interventions
- Provider Prompt & Patient Outreach and Education
Find a Clinic Near You
Who Is Running the Clinical Trial?
Georgetown University
Lead Sponsor